Hong Kong Polytechnic University develops an AI-powered digital twin system that integrates multimodal patient data, including medical imaging, for personalized cancer treatment planning.
Key Details
- 1PolyU's AI Virtual Patient Simulation System uses multimodal data—medical imaging, genomics, and clinical records—to create real-time digital twins of cancer patients.
- 2The system can predict effectiveness of different cancer treatment options, supporting more precise and personalized care.
- 3A novel framework (ViGNet) combining image and genomic data achieved 82.55% accuracy in predicting immunotherapy response for non-small cell lung cancer (NSCLC).
- 4Doctors and patients interact via dedicated platforms, enabling better monitoring and data sharing, including via an encrypted Deep Feature QR code.
- 5System showcased at Mobile World Congress 2026 and was a finalist for the Global Mobile Awards in the health innovation category.
- 6Project received funding from PolyU, GBA Innovation programs, and is advancing to commercialisation.
Why It Matters
This system demonstrates the potential for AI solutions that combine imaging and other data to improve personalization and efficacy in cancer care, enhancing precision medicine and workflow efficiency in clinical practice. Its strong performance and industry recognition signal rising adoption of intelligent, multimodal AI technologies in radiology and oncology.
Source
EurekAlert
Related News
•EurekAlert
TRUECAM AI Framework Boosts Reliability in Cancer Pathology Imaging
PolyU researchers introduce the TRUECAM AI framework to enhance the trustworthiness of pathology AI for cancer diagnosis.
•EurekAlert
Deep Learning Shows Superior Sensitivity in Sinus Disease CT Changes
Automated deep learning achieves greater sensitivity in detecting treatment-related changes in chronic sinus disease on CT scans than standard visual scoring.
•EurekAlert
Mayo Clinic's AI Advances Ultrasound Detection of Heart Obstruction
Mayo Clinic researchers have developed an AI model that detects heart obstructions from routine ultrasound, potentially improving early identification of at-risk patients.